Chimeric antigen receptor T‐cell therapy as a bridge to haematopoietic stem cell transplantation for refractory/relapsed B‐cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Chimeric antigen receptor T‐cell therapy as a bridge to haematopoietic stem cell transplantation for refractory/relapsed B‐cell acute lymphoblastic leukemia

Published:2019-12-23 Issue:1 Volume:189 Page:146-152
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Zhang Yan¹^ORCID,Chen Huiren²,Song Yanzhi¹,Tan Xiyou¹,Zhao Yongqiang¹,Liu Xiaodong²,Li Zhihui¹,Yang Fan¹,Jiang Min¹,Gao Zhiyong¹,Wu Tong¹

Affiliation:

1. Beijing Boren Hospital Beijing China

2. The 7th Medical Center of PLA Army Beijing China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16339

Reference33 articles.

1. Alvarnas J.C. Brown P.A. Advani A. Aoun P. Ballen K.K.(2016)Clinical Practice Guidelines in Oncology: Acute Lymphoblastic Leukemia Version 1. Available at:https://www.nccn.org/professionals/physician_gls/pdf/all.pdf.

2. Stem cell–derived erythroid cells mediate long-term systemic protein delivery

3. Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia

4. The consensus of allogeneic hematopoietic transplantation for hematological diseases in China (2016)‐‐ post‐transplant leukemia relapse;Chinese Society of Hematology, Chinese Medical Association;Zhonghua xue ye xue za zhi=Zhonghua xueyexue zazhi,2016

5. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decitabine consolidation after CD19/CD22 CAR-T therapy as a novel maintenance treatment significantly improves survival outcomes in relapsed/refractory B-ALL patients;Leukemia Research;2024-10

2. Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy;Transplantation and Cellular Therapy;2024-08

3. The road more or less traveled- Examining the role of consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T cell therapy in B-cell ALL;Seminars in Hematology;2024-08

4. Unrelated hematopoietic stem cell donor registries: present reality and future prospects;Current Opinion in Hematology;2024-07-22

5. CD19 chimeric antigen receptor-T cells as bridging therapy to allogeneic hematopoietic cell transplantation improves outcome in patients with refractory/relapsed B-cell acute lymphoblastic leukemia;Heliyon;2024-07